A clinical study on CD33-directed chimeric antigen receptormodified NKcells in patient with refractory or relapsed acute myeloid leukemia

被引：1

作者：

Xia, Leiming ^{[1
]}

Sun, Xiang ^{[1
]}

Liu, Liu ^{[1
]}

Wang, Yi ^{[1
]}

Li, Tan ^{[1
]}

Li, Bin ^{[1
]}

Wolf, Gregory ^{[2
]}

Li, Qiao ^{[2
]}

Yang, Lin ^{[3
]}

Bao, Yangyi ^{[1
]}

机构：

[1] First Peoples Hosp Hefei, Hefei, Anhui, Peoples R China

[2] Univ Michigan, Ann Arbor, MI 48109 USA

[3] Persongen Biomed, Suzhou, Peoples R China

来源：

CANCER RESEARCH | 2018年 / 78卷 / 13期

关键词：

Refractory or relapsed acute myeloid leukemia (R/R AML); CD33; Chimeric antigen receptor (CAR); NK cells; Immunotherapy;

D O I：

10.1158/1538-7445.AM2018-CT060

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

CT060

引用

页数：2

共 50 条

[1] Treatment of CD33-directed Chimeric Antigen Receptor-modified T Cells in One Patient With Relapsed and Refractory Acute Myeloid Leukemia
Wang, Quan-shun
Wang, Yao
Lv, Hai-yan
Han, Qing-wang
Fan, Hui
Guo, Bo
Wang, Li-li
Han, Wei-dong
MOLECULAR THERAPY, 2015, 23 (01) : 184 - 191
[2] CD33-Directed Chimeric Antigen Receptor (CAR) T Cells for the Treatment of Acute Myeloid Leukemia (AML)
Rafiq, Sarwish
Purdon, Terence J.
Schultz, Liora M.
Brentjens, Renier J.
BLOOD, 2016, 128 (22)
[3] Systematic preclinical evaluation of CD33-directed chimeric antigen receptor T cell immunotherapy for acute myeloid leukemia defines optimized construct design
Qin, Haiying
Yang, Lila
Chukinas, John A.
Shah, Nirali
Tarun, Samiksha
Pouzolles, Marie
Chien, Christopher D.
Niswander, Lisa M.
Welch, Anthony R.
Taylor, Naomi
Tasian, Sarah K.
Fry, Terry J.
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (09)
[4] CD33-directed immunotherapy with third-generation chimeric antigen receptor T cells and gemtuzumab ozogamicin in intact and CD33-edited acute myeloid leukemia and hematopoietic stem and progenitor cells
Liu, Yi
Wang, Sanmei
Schubert, Maria-Luisa
Lauk, Annika
Yao, Hao
Blank, Maximilian Felix
Cui, Chunhong
Janssen, Maike
Schmidt, Christina
Goellner, Stefanie
Kleist, Christian
Zhou, Fengbiao
Rahfeld, Jens-Ulrich
Sauer, Tim
Schmitt, Michael
Mueller-Tidow, Carsten
INTERNATIONAL JOURNAL OF CANCER, 2022, 150 (07) : 1141 - 1155
[5] CD33-DIRECTED IMMUNOTHERAPY WITH THIRD-GENERATION CHIMERIC ANTIGEN RECEPTOR T CELLS AND GEMTUZUMAB OZOGAMICIN IN INTACT AND CD33-EDITED ACUTE MYELOID LEUKEMIA AND HEMATOPOIETIC STEM AND PROGENITOR CELLS
Liu, Y.
HUMAN GENE THERAPY, 2022, 33 (7-8) : A14 - A15
[6] ANTI-CD33 CHIMERIC ANTIGEN RECEPTOR THERAPY FOR ACUTE MYELOID LEUKEMIA
O'Hear, Carol
Heiber, Joshua
Geiger, Terrence
PEDIATRIC BLOOD & CANCER, 2014, 61 : S1 - S1
[7] Anti-CD33 Chimeric Antigen Receptor Therapy For Acute Myeloid Leukemia
O'Hear, Carol E.
Heiber, Joshua
Geiger, Terrence L.
BLOOD, 2013, 122 (21)
[8] Anti-CD33 chimeric antigen receptor targeting of acute myeloid leukemia
O'Hear, Carol
Heiber, Joshua F.
Schubert, Ingo
Fey, Georg
Geiger, Terrence L.
HAEMATOLOGICA, 2015, 100 (03) : 336 - 344
[9] Successful treatment of two relapsed/refractory t(8;21) acute myeloid leukemia patients by CD19-directed chimeric antigen receptor T cells
Changju Qu
Zheng Li
Liqing Kang
Ying Wang
Haiping Dai
Jia Yin
Guanghua Chen
Mingqing Zhu
Li Yao
Ting Xu
Xiaopeng Tian
Yang Xu
Jia Chen
Xiaming Zhu
Lei Yu
Depei Wu
Xiaowen Tang
Bone Marrow Transplantation, 2019, 54 : 1138 - 1140
[10] Successful treatment of two relapsed/refractory t(8;21) acute myeloid leukemia patients by CD19-directed chimeric antigen receptor T cells
Qu, Changju
Li, Zheng
Kang, Liqing
Wang, Ying
Dai, Haiping
Yin, Jia
Chen, Guanghua
Zhu, Mingqing
Yao, Li
Xu, Ting
Tian, Xiaopeng
Xu, Yang
Chen, Jia
Zhu, Xiaming
Yu, Lei
Wu, Depei
Tang, Xiaowen
BONE MARROW TRANSPLANTATION, 2019, 54 (07) : 1138 - 1140

← 1 2 3 4 5 →